Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > The share prices says what the market thinks

<< Previous

Bullboard Posts

Next >>

Comment by jammingthepipelineon Jun 30, 2021 7:38pm

77 Views

Post# 33477824

RE:RE:RE:RE:RE:RE:The share prices says what the market thinks

Must be tough bio. Owning so many shares that you can't sell without crippling the share price and management didn't even answer your question. But you are important, don't worry.

<< Previous

Bullboard Posts

Next >>

AtkinsRéalis supports Poland’s nuclear power endeavour